In Turkey, Brazil, Chile, Seychelles and Mongolia, the diagnosis rate increased rather than decreased after the Chinese vaccine was administered, and in Indonesia and Thailand, hundreds of health care workers who had received the vaccine in full were reported to have contracted the disease and even died. At a time when the international community is questioning the effectiveness of the Chinese vaccine, China is speeding up the introduction of “Fubitai”, produced by the German pharmaceutical company BioNTech and distributed by Fosun!
According to the Chinese media Caixin.com, on July 14, Wu Yifang, Chairman and CEO of Hong Kong-listed Fosun Pharmaceuticals, said in response to investors’ questions at the shareholders’ meeting that the validation of the mRNA vaccine “Fubitai” by China’s State Drug Administration has been basically completed, and the expert review has been passed, and the administrative approval phase is being stepped up. The administrative approval phase is underway. According to reports, once introduced, the vaccine will be available in China and may be administered free of charge as a booster shot to the public.
China’s accelerated introduction of foreign vaccines is believed to be related to the poor effectiveness of domestic vaccines. For example, Beijing has provided vaccine donations to several Southeast Asian countries, but the Thai Ministry of Health said on July 11 that more than 600 health care workers who received two doses of the Chinese Kexing vaccine intact have been diagnosed.
Thai authorities announced on July 12 that health care workers who received 2 doses of the Lucozade vaccine will be given a supplemental AZ; people who received the first dose of the Cochin vaccine will have their second dose switched to AZ because a local medical survey found that people who received 2 doses of the Cochin vaccine had a 50% reduction in antibodies every 40 days after completing the second dose.
Indonesia also rumored that at least 10 doctors died in June after receiving two doses of Chinese vaccine. The Indonesian government has decided on the 9th to administer additional doses of Modena vaccine to health care workers.
Even the Chinese authorities seem to have no confidence in the protective power of the domestically administered vaccine, after the Chinese Communist Party celebrated its own epidemic prevention: participants in the celebrations were fully vaccinated with the domestically administered vaccine and still required nucleic acid testing.
It is reported that the vaccination rate in Ruili, Yunnan, where the fourth outbreak occurred in early July, reached 96.92% in Dehong Prefecture, Yunnan Province. This sudden outbreak has led outsiders and local residents to question the usefulness of the Chinese vaccine.